Detection of lung basement membrane-degrading substances in plasma during cardiopulmonary bypass.
D000818:Animals; D001485:Basement Membrane / Q000503:physiopathology*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002403:Cathepsins / Q000037:antagonists & inhibitors; D006801:Humans; D066298:In Vitro Techniques; D008168:Lung / Q000503:physiopathology*; D008171:Lung Diseases / Q000209:etiology* / Q000503:physiopathology; D010447:Peptide Hydrolases / Q000032:analysis / Q000502:physiology; D010949:Plasma / Q000032:analysis*; D011817:Rabbits; D014361:Trypsin Inhibitors / Q000097:blood
D014361:Trypsin Inhibitors; D002403:Cathepsins; D010447:Peptide Hydrolases